GASTRIC-ACIDITY DEPENDENT BIOAVAILABILITY OF CINNARIZINE FROM 2 COMMERCIAL CAPSULES IN HEALTHY-VOLUNTEERS

被引:55
作者
OGATA, H
AOYAGI, N
KANIWA, N
EJIMA, A
SEKINE, N
KITAMURA, M
INOUE, Y
机构
[1] LEDERLE JAPAN LTD,CHEM & FORMULAT LAB,SHIKI,JAPAN
[2] NATL INST HYG SCI,DIV DRUGS,TOKYO 158,JAPAN
关键词
D O I
10.1016/0378-5173(86)90108-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:113 / 120
页数:8
相关论文
共 16 条
[1]  
AKADA S, 1976, J HYG CHEM, V22, P291
[2]  
BIANCHETTI E, 1958, Schweiz Med Wochenschr, V88, P736
[3]  
DELL HD, 1977, Z ANAL CHEM, V284, P126
[4]  
HAYASHI K, 1961, CHIRYOU, V43, P1300
[5]   DETERMINATION OF CINNARIZINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
HUNDT, HKL ;
BROWN, LW ;
CLARK, EC .
JOURNAL OF CHROMATOGRAPHY, 1980, 183 (03) :378-382
[6]  
KIYAMA T, 1960, RINSHO SHOKAKIGAKU, V12, P857
[7]   PLASMA CINNARIZINE LEVELS RESULTING FROM ORAL-ADMINISTRATION AS CAPSULE OR TABLET FORMULATION INVESTIGATED BY GAS-LIQUID-CHROMATOGRAPHY [J].
MORRISON, PJ ;
BRADBROOK, ID ;
ROGERS, HJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (04) :349-352
[8]  
NITCHE V, 1982, J CHROMATOGR, V227, P521
[9]  
OGATA H, 1984, J PHARMACOBIO-DYNAM, V7, P656
[10]  
OGATA H, 1984, INT J CLIN PHARM TH, V22, P175